Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis

World Journal of Gastroenterology

Volumn 18, Issue 8, 2012, Pages 821-832

  Zheng, Xiao Yong ^a   Wei, Ri Bao ^a   Tang, Li ^a   Li, Ping ^a   Zheng, Xiao Dong ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiviral drug; Glucocorticoids; Hepatitis b virus associated glomerulonephritis; Immunosuppressant; Meta analysis

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; CREATININE; ENTECAVIR; GLUCOCORTICOID; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RECOMBINANT ALPHA INTERFERON;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTIBODY TITER; ANTIVIRAL THERAPY; ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG SAFETY; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FUNCTION; LOW DRUG DOSE; MEMBRANOUS GLOMERULONEPHRITIS; META ANALYSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; TREATMENT OUTCOME;

EID: 84857514974     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i8.821     Document Type: Article

References (41)

1. Zhiqiang G, Zhaohui D, Qinhuan W, Dexian C, Yunyun F, Hongtao L, Iloeje UH. Cost of chronic hepatitis B infection in China. J Clin Gastroenterol 2004; 38: S175-S178
2. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004; 24: 198-211.
3. Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991; 324: 1457-1463.
4. Fabrizi F, Dixit V, Martin P. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther 2006; 24: 781-788.
5. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990; 54: 12-17.
6. Taskapan H, Oymak O, Dogukan A, Ozbakir O, Utas C. Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form. Clin Nephrol 2000; 54: 161-1637.
7. Lai FM, Tam JS, Li PK, Lai KN. Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy. Virchows Arch A Pathol Anat Histopathol 1989; 414: 279-284.
8. Zhang Y, Zhou JH, Yin XL, Wang FY. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 2010; 16: 770-777.
9. Fang YQ, Wu P, Li Y, Mao LC, Hu YQ, Tang XL. Antivirus combined with immunosuppressive therapy hepatitis B virus-associated membranous glomerulonephritis those with HBsAg positive and HBV replication. CJITWN 2009; 10: 784-787.
10. Panomsak S, Lewsuwan S, Eiam-Ong S, Kanjanabuch T. Hepatitis-B virus-associated nephropathies in adults: a clinical study in Thailand. J Med Assoc Thai 2006; 89 Suppl 2: S151-S156
11. Wang HY. Diagnosis, mechanism and treatment of hepatitis B virus associated glomerulonephritis. Shijie Yixue Zazhi 2002; 6: 28-31.
12. Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study. Clin Ther 2009; 31: 741-750.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
14. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
15. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
16. Cheng CL, Lou TQ, Zheng ZD, Shi CG, Liu X. Mycophenolate mofetil combined with steroid hormone and lamivudine on the treatment of hepatitis B virus associated glomerulonephritis. Zhongguo Shiyong Neike Zazhi 2005; 25: 1083-1085.
17. Dang YM, Jiang LN, Li GP, Hu JQ, Zhao XR. Efficacy of Mycophenolate mofetil on hepatitis B virus associated nephritis. J Clin Nephrol 2004; 4: 270-271.
18. He LS, Shen YP. Clinical investigation of combined treatment of mycophenolate mofetil and corticosteroid for membranous nephropathy. J Clin Nephrol 2007; 7: 1-4.
19. Liu J, Xin KM, Wang XT, Wang Y. The application of Bailing capsule combined with MMF, prednisone and lamivudine on hepatitis B virus associated nephritis. Chin Tradit Patent Med 2010; 32: 1480-1482.
20. Liu ZH, Yuan F. Entecavir combined steroid therapy of clinical manifestations of nephrotic syndrome in HBV-GN. J Clin Res 2008; 25: 2264-2266.
21. Sun LL, Wu J, Xu CG, Zhang LM, Zhang YQ, Mei CL. Clinical Study of Mycophenolate Mofetil and Lamivudine in the Treatment of Hepatitis B Virus Associated Nephritis. CJITWN 2005; 6: 584-587.
22. Sun XP, Yang Q, Cao XG. Adefovir Dipivoxil combined Sugar Corticosteroid Treated 29 Cases of Hepatitis B Virus Associated Glomerulonephritis. Zhongguo Yiyao Zhinan 2010; 8: 8-11.
23. Tang L, Chen XM, Zhao W, Cui Y. A randomized controlled trial of mycophenolate mofetil treatment in HBV-associated glomerulonephritis. Beijing Yixue 2005; 27: 166-169.
24. Tang Y, Lou TQ, Cheng CL, Wang C, Shi CG, Deng B. Treatment of hepatitis B virus associated glomerulonephritis according to different pathology patterns. Zhongguo Xiandai Yixue Zazhi 2005; 15: 869-872.
25. Wu SB, Wang YD, Xu Y. Study of mycophenolate mofetil and lamivudine in treatment of hepatitis B virus associated glomerulonephritis. Xiandai Zhongxiyi Jiehe Zazhi 2008; 17: 4674-4676.
26. Xia DQ, Cai SF, Yang HR, Sun XP, Wu WB. Clinical analysis of Hepatitis B associated glomerulonephritis (HBV-GN) and intervention effect of lamivudine combined with leflunomide and prednisone. Zhongguo Yixue Chuangxin 2009; 6: 6-8.
27. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, Chan KW, Leung JC, Lai KN. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 2005; 68: 1750-1758.
28. Kusakabe A, Tanaka Y, Kurbanov F, Goto K, Tajiri H, Murakami J, Okuse C, Yotsuyanagi H, Joh T, Mizokami M. Virological features of hepatitis B virus-associated nephropathy in Japan. J Med Virol 2007; 79: 1305-1311.
29. Izzedine H, Massard J, Poynard T, Deray G. Lamivudine and HBV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 828-829.
30. Gonzalo A, Mampaso F, Bárcena R, Gallego N, Ortuño J. Membranous nephropathy associated with hepatitis B virus infection: long-term clinical and histological outcome. Nephrol Dial Transplant 1999; 14: 416-418.
31. Connor FL, Rosenberg AR, Kennedy SE, Bohane TD. HBV associated nephrotic syndrome: resolution with oral lamivudine. Arch Dis Child 2003; 88: 446-449.
32. Du J, Ding GH. Diagnosis and treatment of hepatitis B virus associated glomerulonephritis. J Clin Intern Med 2010; 27: 588-589.
33. Kanaan N, Horsmans Y, Goffin E. Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection. Clin Nephrol 2006; 65: 208-210.
34. Okuse C, Yotsuyanagi H, Yamada N, Ikeda H, Takahashi H, Suzuki M, Kondo S, Kimura K, Koike J, Itoh F. Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine. Clin Nephrol 2006; 65: 53-56.
35. Wen YK, Chen ML. Remission of hepatitis B virus-associated membranoproliferative glomerulonephritis in a cirrhotic patient after lamivudine therapy. Clin Nephrol 2006; 65: 211-215.
36. Leung N. Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues. Liver Int 2011; 31 Suppl 1: 85-89.
37. Zoulim F. Hepatitis B virus resistance to antiviral drugs: where are we going? Liver Int 2011; 31 Suppl 1: 111-116.
38. Cui TG. The problem worthy of attention in the treatment of hepatitis B virus associated glomerulonephritis. J Clin Nephrol 2009; 9: 103-105.
39. Levy M, Gagnadoux MF. Membranous nephropathy following perinatal transmission of hepatitis B virus infection--long-term follow-up study. Pediatr Nephrol 1996; 10: 76-78.
40. Yang PM, Sung JL, Chen DS. HLA-A, B, C and DR antigens in chronic hepatitis B viral infection. Hepatogastroenterology 1989; 36: 363-366.
41. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263-283.